Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 14, 2021

View Archived Issues

Overcoming EGFR-targeted TKI lung cancer resistance

Sulfopin, a new selective Pin1 inhibitor with in vivo anticancer activity in Myc-driven tumors

Engineered microbial therapy for local metabolic modulation of the tumor microenvironment

AMPK is a therapeutic target in PDAC

BDNF and NSE as biomarkers in alcohol use disorder and mood disorder comorbidity

New EGFR inhibitors identified at PharmaBlock Sciences

Heptares Therapeutics describes new GLP-1 and GLP-2 receptor agonists

LG Chem discovers GLP-1 receptor agonists

Beijing Jacobio Pharmaceuticals patents KRAS mutant protein inhibitors

New adenosine receptor antagonists synthesized at Exelixis

Suicide attempters with schizophrenia show increased serum S-100B protein levels

CD38 as therapeutic target for protection against doxorubicin-induced cardiotoxicity

Ikena Oncology targets TEAD transcription in cancer with IK-930

BNIP3L is a molecular target in mitophagy defects and mitochondrial dysfunction

SparingVision and Intellia Therapeutics establish strategic collaboration for ocular diseases

Titan Pharmaceuticals and MUSC enter research agreement on kappa-opioid receptor agonists

Immusoft and Takeda to jointly develop cell therapies for neurometabolic disorders

Preclinical studies show potential of melanocortin agonists PL-8331 and PL-9654 for ocular diseases

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...